IP Verse

Sharp patent opposition analysis

The comprehensive analysis of Sharp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Sharp

Stay updated with the latest patent oppositions filed by Sharp

Patent Number	Title	Applicant	Opposition Date	Opposition Company
EP3322731	Method Of Treating Cancer Using Immune Checkpoint Inhibitor	BRISTOL MYERS SQUIBB	Oct 12, 2021	MERCK SHARP & DOHME
EP2382228	Compositions And Methods Of Treating Inflammatory And Autoimmune Diseases	AMGEN	May 26, 2021	MERCK SHARP & DOHME
EP2188371	Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In Bioreactors	WYETH	Sep 20, 2018	MERCK SHARP & DOHME
EP3009511	Novel Crispr Enzymes And Systems	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	Feb 27, 2018	STRAWMAN
EP2800811	Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription	CHARPENTIER	Feb 8, 2018	TL BRAND
EP2825654	Crispr-Cas Component Systems, Methods And Compositions For Sequence Manipulation	MASSACHUSETTS INSTITUTE OF TECHNOLOGY	Jan 25, 2018	STRAWMAN
EP2425825	Pharmaceutical Preparation Containing Oxycodone And Naloxone	MUNDIPHARMA	Aug 8, 2017	INTAS PHARMACEUTICALS
EP2921557	Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence Manipulation	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	Apr 10, 2017	STRAWMAN
EP2931898	Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation With Functional Domains	PRESIDENT AND FELLOWS OF HARVARD COLLEGE	Dec 5, 2016	STRAWMAN
EP2328623	Method For Reducing The Viral And Microbial Load Of Biological Extracts Containing Solids	NORDMARK PHARMA GMBH	Sep 22, 2015	MURRAY

Top clients of Sharp

Top companies who are the clients of Sharp

Company	Total
STRAWMAN	4
MERCK SHARP & DOHME	3
INTAS PHARMACEUTICALS	1
MURRAY	1
TL BRAND	1